DTC Advertising: The 'Kick Me' Sign On Big Pharma’s Backs

Treating mandatory wholesale acquisition cost disclosure in TV ads as a major drug pricing reform is close to ludicrous. But the broad approval of the action is an important sign of the continued public image cost of the ads to the drug companies.  

Kick Me_261962249_1200.jpg

It has been 20 years since broadcast advertising was first permitted by the US FDA, and apparently the idea remains as unpopular as ever.

That is probably the most important message to take away from HHS’ proposed rule to require companies to include price...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access